Journal Club: Efficacy of Tocilizumab in Early Systemic Sclerosis-Related Interstitial Lung Disease.

ACR Open Rheumatol · 2022 · PMC8843758 · PMID 34761880

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

DISCUSSION The primary endpoint for the focuSSced trial was not met, as the change in skin thickness (mRSS) from baseline to 48 weeks between the tocilizumab group and the placebo group did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.